Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses

Journal:

Molecular Psychiatry

Published:

2025-09-17

DOI:

10.1038/s41380-025-03256-x

Affiliations:

13

Authors:

22

Go to article

Institutions	Authors	Share
University Hospital of Lausanne (CHUV), UNIL, Switzerland	15.333333 15.333333	0.70
University Center for Primary Care and Public Health (Unisanté), Switzerland	2.000000	0.09
Geneva University Hospitals (HUG), Switzerland	2.000000	0.09
Les Toises - Psychiatry and Psychotherapy Center, Switzerland	1.333333	0.06
Bern University Hospital, Switzerland	1.000000	0.05
University of Lausanne (UNIL), Switzerland	0.333333	0.02

Interested in Pharmacology and Pharmaceutical Sciences?